UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal models

Cell research, 2021-01, Vol.31 (1), p.17-24

2021

Volltextzugriff (PDF)

Teicoplanin-loaded chitosan-PEO nanofibers for local antibiotic delivery and wound healing

International journal of biological macromolecules, 2020-11, Vol.162, p.645-656

2020

Volltextzugriff (PDF)

Effects of Microplate Type and Broth Additives on Microdilution MIC Susceptibility Assays

Antimicrobial agents and chemotherapy, 2019-01, Vol.63 (1)

2019

Volltextzugriff (PDF)

Population Pharmacokinetics and Pharmacodynamics of Dalbavancin and C-Reactive Protein in Patients with Staphylococcal Osteoarticular Infections

Clinical pharmacokinetics, 2024-09, Vol.63 (9), p.1271-1282

2024

Volltextzugriff (PDF)

Emergence of Dalbavancin, Vancomycin, and Daptomycin Nonsusceptible Staphylococcus aureus in a Patient Treated With Dalbavancin: Case Report and Isolate Characterization

Clinical infectious diseases, 2022-10, Vol.75 (9), p.1641-1644

2022

Volltextzugriff (PDF)

New Perspectives on Antimicrobial Agents: Long-Acting Lipoglycopeptides

Antimicrobial agents and chemotherapy, 2022-06, Vol.66 (6), p.e0261420-e0261420

2022

Volltextzugriff (PDF)

Clinical Pharmacokinetics and Pharmacodynamics of Dalbavancin

Clinical pharmacokinetics, 2022-03, Vol.61 (3), p.363-374

2022

Volltextzugriff (PDF)

Lipoglycopeptide Antibacterial Agents in Gram-Positive Infections: A Comparative Review

Drugs (New York, N.Y.), 2015-12, Vol.75 (18), p.2073-2095

Van Bambeke, Françoise

2015

Volltextzugriff (PDF)

Dalbavancin Alone and in Combination with Ceftaroline against Four Different Phenotypes of Staphylococcus aureus in a Simulated Pharmacodynamic/Pharmacokinetic Model

Antimicrobial agents and chemotherapy, 2019-04, Vol.63 (4)

2019

Volltextzugriff (PDF)

Update on activity of dalbavancin and comparators against clinical isolates of Gram-positive pathogens from Europe and Russia (2017–2018), and on clonal distribution of MRSA

International journal of antimicrobial agents, 2022-02, Vol.59 (2), p.106503-106503, Article 106503

2022

Volltextzugriff (PDF)

Population pharmacokinetics of teicoplanin and attainment of pharmacokinetic/pharmacodynamic targets in adult patients with haematological malignancy

Clinical microbiology and infection, 2017-09, Vol.23 (9), p.674.e7-674.e13

2017

Volltextzugriff (PDF)

Intravenous and Intraperitoneal Pharmacokinetics of Dalbavancin in Peritoneal Dialysis Patients

Antimicrobial agents and chemotherapy, 2020-04, Vol.64 (5)

2020

Volltextzugriff (PDF)

In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii

Antimicrobial agents and chemotherapy, 2016-11, Vol.60 (11), p.6774-6779

2016

Volltextzugriff (PDF)

Impact of Glycopeptide Resistance in Staphylococcus aureus on the Dalbavancin In Vivo Pharmacodynamic Target

Antimicrobial agents and chemotherapy, 2015-12, Vol.59 (12), p.7833-7836

2015

Volltextzugriff (PDF)

Vancomycin and Ceftazidime in Bone Cement as a Potentially Effective Treatment for Knee Periprosthetic Joint Infection

Journal of bone and joint surgery. American volume, 2017-02, Vol.99 (3), p.223-231

2017

Volltextzugriff (PDF)

In Vivo Effectiveness of Several Antimicrobial Locks To Eradicate Intravascular Catheter Coagulase-Negative Staphylococci Biofilms

Antimicrobial agents and chemotherapy, 2023-01, Vol.67 (1), p.e0126422

2023

Volltextzugriff (PDF)

Glycopeptide and Lipoglycopeptide Antibiotics

Chemical reviews, 2005-02, Vol.105 (2), p.425-448

2005

Volltextzugriff (PDF)

Evaluation of intraosteoblastic activity of dalbavancin against Staphylococcus aureus in an ex vivo model of bone cell infection

Journal of antimicrobial chemotherapy, 2021-11, Vol.76 (11), p.2863-2866

2021

Volltextzugriff (PDF)

Screening and evaluation of approved drugs as inhibitors of main protease of SARS-CoV-2

International journal of biological macromolecules, 2020-12, Vol.164, p.2622-2631

2020

Volltextzugriff (PDF)

Implementation and validation of a Bayesian method for accurately forecasting duration of optimal pharmacodynamic target attainment with dalbavancin during long-term use for subacute and chronic staphylococcal infections

International journal of antimicrobial agents, 2024-01, Vol.63 (1), p.107038-107038, Article 107038

2024

Volltextzugriff (PDF)

Teicoplanin derivatives block spike protein mediated viral entry as pan-SARS-CoV-2 inhibitors

Biomedicine & pharmacotherapy, 2023-02, Vol.158, p.114213-114213, Article 114213

2023

Volltextzugriff (PDF)

Synergistic microbicidal effect of cationic antimicrobial peptides and teicoplanin against planktonic and biofilm-encased Staphylococcus aureus

International journal of antimicrobial agents, 2019-02, Vol.53 (2), p.143-151

2019

Volltextzugriff (PDF)

New Gram-Positive Agents: the Next Generation of Oxazolidinones and Lipoglycopeptides

Journal of clinical microbiology, 2016-09, Vol.54 (9), p.2225-2232

2016

Volltextzugriff (PDF)

Structure-activity relationship studies of lipophilic teicoplanin pseudoaglycon derivatives as new anti-influenza virus agents

European journal of medicinal chemistry, 2018-09, Vol.157, p.1017-1030

2018

Volltextzugriff (PDF)

Evaluation of two commercial broth microdilution systems for dalbavancin susceptibility testing of methicillin-resistant Staphylococcus aureus and other resistant Gram-positive cocci

Clinical microbiology and infection, 2024-07, Vol.30 (7), p.951.e1-951.e4

2024

Volltextzugriff (PDF)

1 – 25 von 1.976

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.861)
Mit Volltextzugriff
(1.579)

Publikationsform

Sprache

7 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.660)
Life Sciences & Biomedicine
(1.624)
Humans
(1.255)
Pharmacology & Pharmacy
(1.066)
Teicoplanin
(1.047)
Anti-Bacterial Agents - Pharmacology
(892)
Microbiology
(882)
Biological And Medical Sciences
(857)
Medical Sciences
(786)
Teicoplanin - Pharmacology
(764)
Infectious Diseases
(747)
Pharmacology. Drug Treatments
(736)
Microbial Sensitivity Tests
(691)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(642)
Vancomycin - Pharmacology
(588)
Antibacterial Agents
(541)
Male
(484)
Female
(427)
Anti-Bacterial Agents - Therapeutic Use
(404)
Vancomycin
(384)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal models

Teicoplanin-loaded chitosan-PEO nanofibers for local antibiotic delivery and wound healing

Effects of Microplate Type and Broth Additives on Microdilution MIC Susceptibility Assays

Population Pharmacokinetics and Pharmacodynamics of Dalbavancin and C-Reactive Protein in Patients with Staphylococcal Osteoarticular Infections

Emergence of Dalbavancin, Vancomycin, and Daptomycin Nonsusceptible Staphylococcus aureus in a Patient Treated With Dalbavancin: Case Report and Isolate Characterization

New Perspectives on Antimicrobial Agents: Long-Acting Lipoglycopeptides

Clinical Pharmacokinetics and Pharmacodynamics of Dalbavancin

Lipoglycopeptide Antibacterial Agents in Gram-Positive Infections: A Comparative Review

Dalbavancin Alone and in Combination with Ceftaroline against Four Different Phenotypes of Staphylococcus aureus in a Simulated Pharmacodynamic/Pharmacokinetic Model

Update on activity of dalbavancin and comparators against clinical isolates of Gram-positive pathogens from Europe and Russia (2017–2018), and on clonal distribution of MRSA

Population pharmacokinetics of teicoplanin and attainment of pharmacokinetic/pharmacodynamic targets in adult patients with haematological malignancy

Intravenous and Intraperitoneal Pharmacokinetics of Dalbavancin in Peritoneal Dialysis Patients

In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii

Impact of Glycopeptide Resistance in Staphylococcus aureus on the Dalbavancin In Vivo Pharmacodynamic Target

Vancomycin and Ceftazidime in Bone Cement as a Potentially Effective Treatment for Knee Periprosthetic Joint Infection

In Vivo Effectiveness of Several Antimicrobial Locks To Eradicate Intravascular Catheter Coagulase-Negative Staphylococci Biofilms

Glycopeptide and Lipoglycopeptide Antibiotics

Evaluation of intraosteoblastic activity of dalbavancin against Staphylococcus aureus in an ex vivo model of bone cell infection

Screening and evaluation of approved drugs as inhibitors of main protease of SARS-CoV-2

Implementation and validation of a Bayesian method for accurately forecasting duration of optimal pharmacodynamic target attainment with dalbavancin during long-term use for subacute and chronic staphylococcal infections

Teicoplanin derivatives block spike protein mediated viral entry as pan-SARS-CoV-2 inhibitors

Synergistic microbicidal effect of cationic antimicrobial peptides and teicoplanin against planktonic and biofilm-encased Staphylococcus aureus

New Gram-Positive Agents: the Next Generation of Oxazolidinones and Lipoglycopeptides

Structure-activity relationship studies of lipophilic teicoplanin pseudoaglycon derivatives as new anti-influenza virus agents

Evaluation of two commercial broth microdilution systems for dalbavancin susceptibility testing of methicillin-resistant Staphylococcus aureus and other resistant Gram-positive cocci

Suchergebnisse filtern